Dr. Amal Roy Choudhary

MBBS, MD (Radiation Oncology)

Director – Department of Radiation Oncology

27+ Years of Experience
Gurgaon

Dr. Amal Roy Choudhary is a nationally renowned Radiation Oncologist with more than 27 years of experience in high-precision, organ-preserving cancer treatments. He completed his MBBS and MD from the Manipal Academy of Higher Education, followed by an advanced fellowship at the All India Institute of Medical Sciences (AIIMS), New Delhi. Dr. Choudhary specializes in delivering precise radiation doses using cutting-edge linear accelerators and stereotactic systems. Known for his meticulous treatment planning and focus on minimizing side effects, he works closely within multidisciplinary tumor boards to craft personalized radiation regimens for challenging and recurrent cancer cases.

  • Stereotactic Radiosurgery (SRS) & SBRT: High-dose, highly targeted radiation for brain tumors, spinal lesions, and early-stage lung cancers.
  • Advanced IMRT & IGRT: Intensity-Modulated and Image-Guided Radiation Therapies to precisely target tumors while protecting surrounding healthy organs.
  • Gated & Adaptive Radiotherapy: Real-time motion management techniques to adjust for patient breathing during radiation delivery.
  • Genitourinary & Abdominal Malignancies: Tailored radiation protocols for prostate, bladder, and gastrointestinal tumors.
  • Head & Neck Radiotherapy: Organ-preserving radiation strategies for oral, laryngeal, and nasopharyngeal cancers.
  • Over his distinguished career, he has successfully delivered precision radiation therapy to more than 15,000 cancer patients.
  • Served with distinction as Associate Director at Max Healthcare and Associate Consultant at the Rajiv Gandhi Cancer Institute (RGIRC).
  • Actively published multiple scientific research papers on precision radiation planning in indexed national and international medical journals.
  • Honored with the Indian Society for Radiation and Cellular Biology Distinguished Service Award for outstanding contributions to modern radiotherapy.
  • Active member of prestigious global oncology bodies, including the American Society for Radiation Oncology (ASTRO) and the European Society for Radiotherapy and Oncology (ESTRO).